Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ostergaard

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Cancer Research|October 27, 1997
Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiationM Ostergaard, H H Rasmussen, H V Nielsen, et al.
Journal of Virology|January 1, 1997
Mapping of a major osteomagenic determinant of murine leukemia virus RFB-14 to non-long terminal repeat sequencesM Ostergaard, L Pedersen, J Schmidt, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|June 3, 2010
Ultrasound and MRI measurements of joint cartilage in healthy children: a validation studyA H Spannow, E Stenboeg, M Pfeiffer-Jensen, et al.
Annals of the Rheumatic Diseases|May 11, 2007
High-grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral boneF M McQueen, A Gao, M Ostergaard, et al.
Scandinavian Journal of Rheumatology|July 10, 2008
Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexateHp Sennels, S Sørensen, M Ostergaard, et al.
Osteoarthritis and Cartilage|April 13, 2001
Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathologyB Volck, J S Johansen, M Stoltenberg, et al.
FEBS Letters|September 1, 2000
Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomicsJ E Celis, M Kruhøffer, I Gromova, et al.
Scandinavian Journal of Rheumatology|May 21, 2005
Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO)M L Hetland, J Unkerskov, T Ravn, et al.
Electrophoresis|April 10, 1999
Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activitiesA Celis, H H Rasmussen, P Celis, et al.
Cancer Research|June 26, 1999
Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesionsJ E Celis, P Celis, M Ostergaard, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Cancer Research|October 27, 1997
Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiationM Ostergaard, H H Rasmussen, H V Nielsen, et al.
Journal of Virology|January 1, 1997
Mapping of a major osteomagenic determinant of murine leukemia virus RFB-14 to non-long terminal repeat sequencesM Ostergaard, L Pedersen, J Schmidt, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|June 3, 2010
Ultrasound and MRI measurements of joint cartilage in healthy children: a validation studyA H Spannow, E Stenboeg, M Pfeiffer-Jensen, et al.
Annals of the Rheumatic Diseases|May 11, 2007
High-grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral boneF M McQueen, A Gao, M Ostergaard, et al.
Scandinavian Journal of Rheumatology|July 10, 2008
Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexateHp Sennels, S Sørensen, M Ostergaard, et al.
Osteoarthritis and Cartilage|April 13, 2001
Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathologyB Volck, J S Johansen, M Stoltenberg, et al.
FEBS Letters|September 1, 2000
Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomicsJ E Celis, M Kruhøffer, I Gromova, et al.
Scandinavian Journal of Rheumatology|May 21, 2005
Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO)M L Hetland, J Unkerskov, T Ravn, et al.
Electrophoresis|April 10, 1999
Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activitiesA Celis, H H Rasmussen, P Celis, et al.
Cancer Research|June 26, 1999
Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesionsJ E Celis, P Celis, M Ostergaard, et al.
Pageof 6